This inventor holds 1 USPTO granted patent. Top assignee: The University of Texas System. Active years: 2019.
Company Filing History:
Years Active: 2019
Title: Marli Tenorio: Innovator in Dengue Hemorrhagic Fever Detection
Introduction
Marli Tenorio is a notable inventor based in Recife, Brazil. He has made significant contributions to the field of medical diagnostics, particularly in the detection of dengue hemorrhagic fever (DHF). His innovative work focuses on identifying biomarkers that can help diagnose patients at risk of developing this serious condition.
Latest Patents
Marli Tenorio holds a patent for a method and biomarkers for the detection of dengue hemorrhagic fever. The patent, titled "Method and biomarkers for the detection of dengue hemorrhagic fever," provides compositions and methods for detecting, analyzing, and identifying biomolecules used to diagnose patients with a risk of DHF. Specifically, the invention highlights the importance of the plasma biomarkers, including the complement factor D to complement factor H (FactorD/FactorH) ratio, as well as levels of one or more of IL2, desmoplakin, and high molecular weight albumin. These biomarkers are crucial for detecting the risk of developing DHF.
Career Highlights
Marli Tenorio is affiliated with the University of Texas System, where he continues to advance research in medical diagnostics. His work has garnered attention for its potential to improve patient outcomes in dengue fever cases.
Collaborations
Throughout his career, Marli has collaborated with esteemed colleagues, including Ernesto E T Marquez and Heidi Spratt. These collaborations have further enriched his research and contributed to the development of innovative diagnostic methods.
Conclusion
Marli Tenorio's contributions to the detection of dengue hemorrhagic fever through innovative biomarker identification exemplify the impact of research in medical diagnostics. His work not only enhances our understanding of DHF but also paves the way for improved diagnostic techniques.